Only 5 Canadian licensed producers (LPs), out of the 950 who are licensed by Health Canada to cultivate, process and sell cannabis for medical or non-medical purposes (see here), are publicly traded with market capitalizations of at least $300M and the munKNEE Canadian Cannabis LPs Index tracks their performances.

This article highlights the performance of each of the 5 constituents this week, in descending order, and YTD, with links to summary articles on each of their latest quarter financial results and a link to a recent article which highlights the financial health of each constituent.

1. Aurora (ACB): UP 3.9% this week; UP 19.1% YTD
   • Read: Aurora Cannabis Q1 Financials Show Improvement: Stock Jumps 18%
2. Cronos (CRON): No Change this week; DOWN 1.1% YTD
   • Read: Cronos Group Q3 Financial Report Disappointing: Stock Declines 10%
3. Canopy Growth (CGC): DOWN 0.3% this week; UP 28.6% YTD
   • Read: Canopy Growth Q2 Financial Report: Loss In Net Income Reduced Dramatically
4. Tilray (TLRY): DOWN 0.3% this week; UP 19.9% YTD
   • Read: Tilray Brands: Q2 Financial Metrics All Declined
5. OrganiGram (OGI): DOWN 1.1% this week; UP 16.8% YTD
   • Read: Organigram Reports A Net Profit In Q1

In total, the munKNEE Canadian Cannabis LPs Index went UP only 0.1% this week and is now UP 15.9% YTD. Our American Cannabis MSO Stocks Index, in comparison, went UP 7.3% this week, and is now UP 2.0% YTD.

More By This Author:

A Comparison Of 7 Cannabis Portfolio Performances YTD And Last Week
The "Rags-To-Riches" Portfolio Update: Week Ending January 27
The "Multi-Bagger" Portfolio Update: Week Ending January 27